GLP-1 Analogues Market Set to Surpass USD 211.8 Billion by 2035 as Demand for Diabetes and Obesity Therapies Accelerates
The global GLP-1 analogues market is witnessing significant growth, fueled by the increasing burden of type 2 diabetes and obesity worldwide. Valued at US$ 51.6 billion in 2024, the market is projected to reach US$ 211.8 billion by 2035, expanding at a strong CAGR of 13.7% from 2025 to 2035. The rising prevalence of metabolic disorders, advancements in drug formulations, and...
0 التعليقات 0 المشاركات 36 مشاهدة 0 معاينة